Transcription factors in hematopoiesis

Current Opinion in Genetics and Development

Volumn 9, Issue 5, 1999, Pages 575-579

  Engel, Isaac ^a   Murre, Cornelis ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CELL LINEAGE; CHROMATIN STRUCTURE; GENE TARGETING; HEMATOPOIESIS; LEUKEMOGENESIS; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0032860087     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(99)00008-8     Document Type: Review

References (53)

1. Graf T, Mcnagny K, Brady G, Frampton J Chicken erythroid cells transformed by the gag-myb-ets-encoding E26 leukemia virus are multipotent. Cell. 70:1992;201-213.
2. Nerlov C, Graf T PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12:1998;2403-2412. Nerlov and Graf have transduced multi-potential chicken cells with inducible forms of PU.1 to confirm a role for this protein in myeloid commitment. The authors also demonstrate that the transactivation domain of PU.1 is necessary for its function in biasing differentiation, and that transient expression of PU.1 can lead to an immature eosinophil-like phenotype.
3. Scott EW, Simon MC, Anastasi J, Singh H Requirement of the transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
4. Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC, Singh H PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity. 6:1997;437-447.
5. McKercher S, Torbett B, Anderson K, Henkel G, Vestal D, Garibault H, Klemsz M, Feeney A, Wu G, Paige C, Maki R Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
6. ••], the authors propose a model in which PU.1 and C/EBP stimulate, and GATA-1 opposes, myeloid and eosinophil differentiation.
7. Heemskerk MHM, Blom B, Nolan G, Stegmann APA, Bakker AQ, Weijer K, Res PCM, Spits H Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med. 186:1997;1597-1602.
8. •].
9. •].
10. Pallard C, Stegmann APA, van Kleffens T, Smart F, Venkitaraman A, Spits H Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity. 10:1999;525-535. Pallard et al. test the effect of inhibition of the IL7/STAT 5 signaling pathway, through forced expression of dominant negative forms of both STAT 5 and a chimeric IL-7 receptor on T-cell development, in their FTOC differentiation assay. Differentiation of αβ T-cells is blocked by the disruption of signaling through IL7/STAT 5. The authors also identify a role for signaling through phosphatidylinositol 3-kinase and protein kinase B in thymocyte proliferation and survival.
11. Bain G, Maandag E, Izon D, Amsen D, Kruisbeek A, Weintraub B, Krop I, Schlissel M, Feeney A, van Roon Met al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell. 79:1994;885-892.
12. Zhuang Y, Soriano P, Weintraub H The helix-loop-helix gene E2A is required for B cell formation. Cell. 79:1994;875-884.
13. Lin H, Grosschedl R Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature. 376:1995;263-267.
14. Kee BL, Murre C Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med. 188:1998;699-713. Kee and Murre provide evidence that E2A functions upstream of EBF on the basis of the ability of these factors to convert the 70Z/3 macrophage line to a pre-B-like phenotype.
15. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev. 6:1992;2620-2634.
16. Kim HK, Siu G The notch pathway intermediate HES-1 silences CD4 gene expression. Mol Cell Biol. 18:1998;7166-7175.
17. Ishibashi M, Ang S-L, Shiota K, Nakanishi S, Kageyama R, Guillemot F Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to upregulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes Dev. 9:1995;3136-3148.
18. ••].
19. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott JWJ, Potter SS A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 65:1991;677-689.
20. ••]. Hes-1 was found to be required for the differentiation and expansion of DN thymocytes, whereas thymocytes deficient for c-Myb express markers arrested at the earliest defined stage of T-cell commitment. The c-Myb-null ES cells also failed to contribute to the B-cell or macrophage lineages.
21. •].
22. •] demonstrate the requirement for Ets-1 and Id2 in the development of NK cells. Mice deficient in Id2 were also found to lack lymph nodes and Peyer's patches.
23. Voronova AF, Lee F The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin-6 induced myeloid differentiation. Proc Natl Acad Sci USA. 91:1994;5952-5956.
24. Hsu H-L, Cheng JT, Chen Q, Baer R Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol. 11:1991;3037-3042.
25. Orkin SH, Zon LI Genetics of erythropoiesis: induced mutations in mice and zebrafish. Annu Rev Genet. 31:1997;33-60.
26. Aplan PD, Nakahara K, Orkin SH, Kirsch IR The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11:1992;4073-4081.
27. Visvader JE, Fujiwara Y, Orkin SH Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12:1998;473-479. Visvader et al. find that although the early hematopoietic defect of SCL could be rescued by a transgene that placed a SCL cDNA under control of the GATA-1 promoter, vitelline vessel formation was defective and the embryos died by E9.5.
28. ••].
29. ••] find that the hematopoietic and angiogenic defects of cloche are corrected by enforced expression of SCL, thus demonstrating that SCL acts downstream of cloche. More work is needed to resolve whether SCL actually functions to specify the formation of a hemangioblast stem cell in mice and zebrafish, or whether it only acts separately in the development of both lineages.
30. Warren AJ, Colledge WH, Carlton MBL, Evans MJ, Smith AJH, Rabbitts TH The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell. 78:1994;45-58.
31. •].
32. Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb/NL1 proteins. EMBO J. 16:1997;3145-3157.
33. •] characterized the sequences bound by complexes defined in erythroid cells as containing SCL and LMO2.
34. Bash RO, Hall S, Timmons CF, Crist WM, Amylon M, Smith RG, Baer R Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study. Blood. 86:1995;666-676.
35. Ono Y, Fukuhara N, Yoshie O Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J Biol Chem. 272:1997;4576-4581.
36. Rabbitts TH LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev. 12:1998;2651-2657.
37. •].
38. •].
39. •].
40. Hsu H-L, Wadman I, Tsan JT, Baer R Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci USA. 91:1994;5947-5951.
41. Park ST, Sun X-H The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition. J Biol Chem. 273:1998;7030-7037.
42. Bain G, Engel I, Maandag ECR, te Riele HPJ, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol. 17:1997;4782-4791.
43. Yan W, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y High Incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol. 17:1997;7317-7327.
44. •].
45. •]. We observe that either E2A-encoded protein act to kill these lines, but unlike Park et al., find no effect on cell-cycle progression.
46. Nichogiannopoulou A, Trevisan M, Friedrich C, Georgopoulos K Ikaros in hemopoietic lineage determination and homeostasis. Sem Immunol. 10:1998;119-125.
47. •].
48. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell. 91:1997;845-854.
49. •].
50. •] find that both Ikaros and Aiolos are associated with chromatin-remodeling and histone deacetylation complexes in T-cells.
51. Geiger H, Sick S, Bonifer C, Muller AM Globin gene expression is reprogrammed in chimeras generated by injecting adult hematopoietic stem cells into mouse blastocysts. Cell. 93:1998;1055-1065. Geiger et al. use tranplantation of embryonic/fetal and adult HSCs into adult and blastocyst host environments, respectively, to examine the influence of microenvironment on the expression of a transgenic human globin locus. They find that both adult and embryonic hosts function in a dominant fashion to reprogram gene expression of the transplanted HSCs.
52. •].
53. •] find that differentiation of naïve T-helper populations into different polarized T-helper subsets (i.e. Th1 and Th2) is associated with changes in chromatin structure at the appropriate gene loci, as determined by Dnase hypersensitivity.